MEDITOR GROUP LTD Esperion Therapeutics, Inc. Transaction History

MEDITOR GROUP LTD portfolio value:

$29.94M
portfolio value

MEDITOR GROUP LTD quarter portfolio value change:

+5.35%
quarter

Esperion Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 1.52M $6.7 4.46M
Q2 2022 share 0.00% 0 shares 7.68M $6.36 4.46M
Q1 2022 share 0.00% 0 shares -1.60M $4.64 4.46M
Q4 2021 share Increase +58.53% 1.65M shares -11.62M $4.96 4.46M
Q3 2021 share 0.00% 0 shares -25.65M $12.05 2.81M
Q2 2021 share Increase +5.19% 139K shares -15.55M $21.15 2.81M
Q1 2021 share 0.00% 0 shares 5.49M $28.05 2.67M
Q4 2020 share 0.00% 0 shares -29.93M $26 2.67M
Q3 2020 share 0.00% 0 shares -37.89M $37.17 2.67M
Q2 2020 share 0.00% 0 shares 69.35M $51.31 2.67M
Q1 2020 share 0.00% 0 shares -52.47M $31.53 2.67M
Q4 2019 share 0.00% 0 shares 22.37M $59.63 2.67M
Q3 2019 share 0.00% 0 shares -26.42M $36.66 2.67M
Q2 2019 share 0.00% 0 shares 17.07M $46.52 2.67M
Q1 2019 share 0.00% 0 shares -15.67M $40.15 2.67M
Q4 2018 share Increase +1.90% 50K shares 6.58M $46 2.67M
Q3 2018 share 0.00% 0 shares 13.62M $44.37 2.62M
Q2 2018 share Increase +1.57% 40.6K shares -84.21M $39.19 2.62M
Q1 2018 share Increase +11.47% 266.4K shares 34.34M $72.33 2.58M
Q4 2017 share Increase +1.22% 27.9K shares 37.91M $65.84 2.32M
Q3 2017 share Increase +305.47% 1.72M shares 88.82M $50.12 2.29M
Q2 2017 share Increase 0.00% 566K shares 26.19M $46.28 566K